The goal of seamless enterprise-wide image access and distribution faces a major obstacle: Health Level 7 message incompatibility continues to constitute a technical barrier to broader PACS adoption in cardiology and orthopedics.
The goal of seamless enterprise-wide image access and distribution faces a major obstacle: Health Level 7 message incompatibility continues to constitute a technical barrier to broader PACS adoption in cardiology and orthopedics.
Conformance to standard HL7 message format is the ultimate bridge over this obstacle, but sources predict it will take years before vendors fully adopt a standard message format that achieves total cross-platform compatibility. As a result, many institutions use brokers to interface information systems and PACS.
"Current trends are moving to a brokerless environment, with PACS embedded with HL7 interfaces and informatics-PACS alliances developing elegant integrations. But this could take 10 years or more to achieve," said Chris Walker, CEO of the California-based Cardio-Vascular Sales.
What progress has been made has occurred at a slower pace than most clinicians would prefer.
Excluding digital cardiac cath labs, PACS has penetrated only about 10% of hospital cardiology departments, according to Walker. Radiology PACS, on the other hand, is present in over 50% of U.S. hospitals.
Jacques Cornet, a vice president at Cedara Software, cited several other challenges to broader cardiology PACS adoption:
Many technology vendors who currently offer clinical PACS in this area provide solutions that limit institutional connectivity as either cardiology PACS or radiology PACS - not as a seamless, integrated enterprise-wide system.
"This approach only serves to develop further information/image silos within the healthcare enterprise," Cornet said.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.